Factors influencing pharmacists' adoption of prescribing: Qualitative application of the diffusion of innovations theory

Implementation Science

Volumn 8, Issue 1, 2013, Pages

  Makowsky, Mark J ^a   Guirguis, Lisa M ^a   Hughes, Christine A ^a   Sadowski, Cheryl A ^a   Yuksel, Nese ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CANADA; CLINICAL PRACTICE; FEMALE; HUMAN; MALE; MASS COMMUNICATION; PHARMACIST; PRESCRIPTION; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; THEORETICAL MODEL;

ALBERTA; DIFFUSION OF INNOVATION; DRUG PRESCRIPTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MODELS, THEORETICAL; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL ROLE; QUALITATIVE RESEARCH;

EID: 84883698083     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-8-109     Document Type: Article

References (35)

1. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci 2005, 8(2):217-225.
2. MacLeod-Glover N. An explanatory policy analysis of legislative change permitting pharmacists in Alberta, Canada, to prescribe. Int J Pharm Pract 2011, 19(1):70-78.
3. Cross-jurisdictional scan of legislative and policy framework. [http://blueprintforpharmacy.ca/resources/resource-article/2011/10/19/cross-jurisdictional-scan-of-legislative-and-policy-framework].
4. Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm 2008, 65(22):2126-2132.
5. Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. American Journal of Health-System Pharmacy 2006, 63(3):244-253.
6. List of States by Statutory and Regulatory Authority. [http://www.ashp.org/s_ashp/docs/files/GAD_cdtm8-06chart.pdf].
7. Rogers EM. Diffusion of Innovations: Fourth ed 1995, New York: The Free Press.
8. Berwick DM. Disseminating innovations in health care. JAMA 2003, 289(15):1969-1975.
9. Pronk MCM, Blom ATG, Jonkers R, Van Burg A. The diffusion process of patient education in Dutch community pharmacy: an exploration. Patient Educ Couns 2001, 42(2):115-121.
10. Westrick SC, Mount JK. Impact of perceived innovation characteristics on adoption of pharmacy-based in-house immunization services. Int J Pharm Pract 2009, 17(1):39-46.
11. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q 2004, 82(4):581-629.
12. Guirguis L, Cooney D, Dolovich L, Eberhart G, Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N. Exploring pharmacists' understanding and adoption of prescribing in 2 Canadian jurisdictions: Design and rationale for a mixed-methods approach. Can Pharm J 2011, 144(5):240-244. e1.
13. Thorne SE. Interpretive description 2008, Walnut Creek, CA: Left Coast Press.
14. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of models and frameworks for change. Int J Pharm Pract 2006, 14:105-113.
15. Doucette WR, DeSloover Koch Y. Exploratory study of community pharmacy practice change. J Am Pharm Assoc 2000, 40:384-391.
16. Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Aslani P. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci 2003, 25(5):227-234.
17. Farris KB, Ascione FJ, Kirking DM. Characteristics associated with the acceptance of patient medication information sheets among michigan pharmacists. J Pharm Mark Manage 1993, 7(3):25-47.
18. Westrick SC. Forward and backward transitions in pharmacy-based immunization services. Res Social Adm Pharm 2010, 6(1):18-31.
19. Fedder DO, Levine DL, Patterson Russell R, Lewis C, Lamy PP. Strategies to implement a patient counseling and medication tickler system - A study of Maryland pharmacists and their hypertensive patients. Patient Educ Couns 1988, 11(1):53-64.
20. Rapport F, Doel MA, Jerzembek GS. "Convenient space" or "a tight squeeze": insider views on the community pharmacy. Health Place 2009, 15(1):315-322.
21. Weiss MC, Sutton J. The changing nature of prescribing: pharmacists as prescribers and challenges to medical dominance. Sociol Health Illn 2009, 31(3):406-421.
22. Pottie K, Haydt S, Farrell B, Kennie N, Sellors C, Martin C, Dolovich L,IMPACT team members Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT project. Res Social Adm Pharm 2009, 5(4):319-326. IMPACT team members.
23. Snyder ME, Zillich AJ, Primack BA, Rice KR, Somma McGivney MA, Pringle JL, Smith RB. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm 2010, 6(4):307-323.
24. Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: A conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm 2012, 8(1):36-46.
25. Guirguis LM, Chewning BA. Role theory: literature review and implications for patient-pharmacist interactions. Res Social Adm Pharm 2005, 1(4):483-507.
26. Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract 2011, 19(6):381-382.
27. Hoti K, Hughes J, Sunderland B. Pharmacy clients' attitudes to expanded pharmacist prescribing and the role of agency theory on involved stakeholders. Int J Pharm Pract 2011, 19(1):5-12.
28. Dawoud D, Griffiths P, Maben J, Goodyer L, Greene R. Pharmacist supplementary prescribing: A step toward more independence?. Res Social Adm Pharm 2011, 7(3):56-246.
29. Tully MP, Latif S, Cantrill JA, Parker D. Pharmacists' changing views of their supplementary prescribing authority. Pharm World Sci 2007, 29(6):628-634.
30. Lloyd F, Parsons C, Hughes CM. 'It's showed me the skills that he has': pharmacists' and mentors' views on pharmacist supplementary prescribing. Int J Pharm Pract 2010, 18(1):29-36.
31. Hobson RJ, Sewell GJ. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci 2006, 28(2):76-90.
32. Stewart DC, George J, Bond CM, Diack HL, McCaig DJ, Cunningham S. Views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. Int J Pharm Pract 2009, 17(2):89-94.
33. Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P. Stakeholders' views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy 2008, 13(4):215-221.
34. Blenkinsopp A, Tann J, Evans A, Grime J. Opportunity or threat? General practitioner perceptions of pharmacist prescribing. Int J Pharm Pract 2008, 16(1):29-34.
35. Weiss MC. Diagnostic decision making: The last refuge for general practitioners?. Soc Sci Med 2011, 73(3):82-375.